奥泰生物(688606.SH)上半年净利润1.32亿元，同比增长6.57%

Group 1 - The core viewpoint of the article is that Aotai Biologics (688606.SH) reported its semi-annual results for 2025, showing positive growth in revenue and net profit [1] - The company achieved an operating income of 430 million yuan, representing a year-on-year increase of 8.41% [1] - The net profit attributable to shareholders of the listed company was 132 million yuan, reflecting a year-on-year growth of 6.57% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 109 million yuan, which is a year-on-year increase of 17.27% [1] - The basic earnings per share were reported at 1.67 yuan [1]